We wanted to determine new biomarkers in connection with the influence of renal function on CV complications in IgAN, such as heart failure and atherosclerotic disease prediction, and detection of any association between NT-proBNP as a marker of heart failure, CITP as a marker of atherosclerosis and myocardial fibrosis, and CKD. Here, NPPB is linked to chronic kidney disease.